Clinical Trial Update: Serum Uromodulin and DN Systematic Review and Meta Analysis

View source ↗

Summary

A completed systematic review and meta-analysis evaluating serum uromodulin as a biomarker in diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: Tanta University | Conditions: Diabetic Nephropathies | Status: COMPLETED